The CRLB-GMEL team is hosting a event about “multiomics,” the approach where data sets of different ”omic groups – genomics, proteomics, transcriptomics, epigenomics and microbiomics – are combined during analysis in a genetic and molecular laboratory.
Multiomics Day – being held Tuesday, September 27, 12 – 5 pm ET, in person and virtually – is the first time the PHRI and HHS joint lab, CRLB-GMEL, has hosted such an event. The intention is to share knowledge about the exciting, burgeoning field of multiomics and the services of the lab as well as suppliers Olink and Illumina, sponsors of the day.
The day’s agenda includes:
- Introduction on the genetic analysis and bioinformatics services provided by the CRLB-GMEL laboratory.
- Michael Förster, Olink, Scientific Director, Oncology & Rare Disease, Olink, on targeted protein screening for biomarker discovery in health and disease.
- Douglas D. Fraser, Professor and Clinician-Scientist, Western University, on Covid-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high precision disease management.
- Lisa Lock, Senior Sequencing Specialist, Illumina on the company’s technology and application updates.
- Allison Boyd, Research Associate, Mick Bhatia’s lab, McMaster, on high-resolution profiling of functionally relevant cells in acute myeloid leukemia.
Those attending in person will be served lunch as well as refreshments at a mid-afternoon coffee break. Location: Alumni Memorial Building, McMaster University, 1280 Main St W, Hamilton, Ontario L8S 4L8.